BIS Reaches Administrative Enforcement Settlement with Plexon, Inc.
# #LL#!" &L L! # "&L #!L ""LL L !E.H/=L7C5.BL ,E7=4L7B.,E>BL>0LJ@>BEL=3?B,.<.=FL )E.L ''''''''''''L 'L %L L *BH.KL$L$7447=CL 57.0LJ.,GF7H.L129,/BL .H7.I/-L)=-L)@@B>H.-L+K L >6LL.CE/BLCAL ;7H.BLLB7D,58:LDAL 7,5)/;LL!<7F5LCAL L*IL L )E.L G4GCFL L STEVEN FISHER Digitally signed by STEVEN FISHER Date: 2026.08.14 07:21:46 -04'00' UNITED STATES DEPARTMENT OF COMMERCE Bureau of Industry and Security Office of Export Enforcement 1401 Constitution Avenue, Suite 4508 Washington, DC 20230 PROPOSED CHARGING LETTER Plexon, Inc. ATTN: Harvey W. Wiggins, CEO 6500 Greenville Ave. Suite 730 Dallas, TX 75206 Dear Mr. Wiggins, The Bureau of Industry and Security, U.S. Department of Commerce (“BIS”), has reason to believe that Plexon, Inc. (“Plexon” or “Respondent”) has committed eight violations of the Export Administration Regulations (the “EAR” or “Regulations”). 1 Specifically, BIS alleges the following: GENERAL ALLEGATIONS 1. As described further below and in the attached Schedule of Violations, on or about February 10, 2022, through August 30, 2023, Plexon violated the Regulations when it exported items subject to the EAR to parties in China listed on the BIS Entity List, without the required license or authorization from BIS. Specifically, Plexon exported eight Neural Recording Data Acquisition Systems (“Omniplex systems”) and accessories to the Academy of Military Medical Sciences (AMMS), a party on the BIS Entity List. At all relevant times, pursuant to § 744.11 of the Regulations, a license was required for the export, reexport or transfer (in-country) of items subject to the EAR to this end user. 2. Plexon, Inc. is a small U.S. neuroscience technology company headquartered in Dallas, Texas. Although the company’s sole U.S. facility is in Dallas, Texas, the company has authorized distributors in China, Russia, South Korea, and Japan. Plexon’s Asian distributor acts as its sales branch in Asia (except Japan) and has offices in Hong Kong, Beijing, Shanghai, Nanjing, and Guangzhou. 3. The OminiPlex system, manufactured at Plexon’s U.S. facility in Dallas, Texas, is a machine that uses electrodes placed in the brains of animals to acquire data and to identify and categorize spikes made by individual neurons in the brain. The OmniPlex system is a 1 The Regulations are currently codified in the Code of Federal Regulations at 15 C.F.R. Parts 730-774 (2025). The charged violations occurred in 2022. The Regulations governing the violations at issue are found in the 2022 through 2023 versions of the Code of Federal Regulations (15 C.F.R. Parts 730-774 (2022 - 2023)). The 2025 Regulations set forth the procedures that apply to this matter. Page 2 of 5 combination of the OmniPlex chassis, OmniPlex Software, and a Digital Headstage Processor (DHP) acquisition subsystem. 4. Section 1758 of the Export Control Reform Act of 2018 authorizes Commerce to establish appropriate controls on the export, reexport, or transfer (in-country) of emerging technologies essential to the national security of the United States. In an Advance Notice of Proposed Rulemaking (ANPRM) in 2018, BIS identified brain-computer interfaces (BCI), artificial intelligence for brain modelling, and other items as potential emerging technologies that could be determined to be essential to the national security of the United States. 2 Subsequently, BIS requested comments from the public on the imposition of export controls on certain BCI in 2021, and held a February 2023 conference intended to further both BIS’s and the public’s understanding of advancements in BCI technology and anticipated future developments in research and applications. 3 STATEMENT OF CHARGES Charges 1-8 15 C.F.R. § 764.2(a) – Engaging in Prohibited Conduct 5. Between on or about February 10, 2022 and August 30, 2023, Plexon engaged in conduct prohibited by the EAR on 8 occasions when it exported Neural Recording Data Acquisition Systems (“Omniplex systems”) and accessories, valued at approximately $178,721 and classified under Export Control Classification Number (ECCN) 4A994.k, to AMMS, a party on the BIS Entity List, without the required license or other authorization from BIS. 6. Pursuant to an existing sales relationship, AMMS ordered the Omniplex systems through Plexon Inc’s Asia distributor. Plexon Inc. then manufactured the systems at its plant in Dallas, Texas and shipped them through its Asian distributor to AMMS. 7. AMMS and eleven of its research institutes were added to the BIS Entity List effective December 17, 2021, due to its “use [of] biotechnology processes to support Chinese military end uses and end users, to include purported brain-control weaponry.” 4 At all times relevant to this conduct, exports to AMMS required a BIS license pursuant to Section 744.11 and Supplement No. 4 to Part 744 of the EAR. Plexon did not seek or obtain BIS authorization for these transactions. 2 Review of Controls for Certain Emerging Technologies , 83 Fed. Reg. 58201 (Nov. 19, 2018). 3 See Request for Comments Concerning the Imposition of Export Controls on Certain Brain-Computer Interface (BCI) Emerging Technology , 86 Fed. Reg. 59070 (Oct. 26, 2021); Imposition of Export Controls on Certain Brain- Computer Interface Emerging Technology , available at https://www.regulations.gov/document/BIS-2021-0032- 0001; Meetings: Brain Computer Interface; Conference , available at https://www.regulations.gov/document/BIS- 2021-0032-0020. 4 See Addition of Certain Entities to the Entity List and Revision of an Entry on the Entity List , 86 Fed. Reg. 71558 (2021). Page 3 of 5 * * * * * Accordingly, Plexon is hereby notified that an administrative proceeding is instituted against it pursuant to Part 766 of the Regulations for the purpose of obtaining an order imposing administrative sanctions, including, but not limited to, any or all of the following: x The maximum civil penalty of an amount not to exceed the greater of $374,474 per violation or an amount that is twice the amount of the transaction that is the basis of the violation with respect to which the penalty is imposed; 5 x Denial of export privileges; x Exclusion from practice before BIS; and/or x Any other liability, sanction, or penalty available under law. If Plexon fails to answer the charges contained in this letter within 30 days after being served with notice of issuance of this letter, that failure will be treated as a default. See 15 C.F.R. §§ 766.6 and 766.7. If Plexon defaults, the Administrative Law Judge may find the charges alleged in this letter are true without a hearing or further notice to Plexon. The Under Secretary of Commerce for Industry and Security may then impose up to the maximum penalty for the charges in this letter. Plexon is further notified that it is entitled to an agency hearing on the record if it files a written demand for one with any answer. See 15 C.F.R. § 766.6. Plexon is also entitled to be represented by counsel or other authorized representative who has power of attorney to represent it. See 15 C.F.R. §§ 766.3(a) and 766.4. The Regulations provide for settlement without a hearing. See 15 C.F.R. § 766.18. Should Plexon have a proposal to settle this case, it should transmit it to the attorney representing BIS named below. Respondents are further notified that under the Small Business Regulatory Enforcement Flexibility Act, Respondents may be eligible for assistance from the Office of the National Ombudsman of the Small Business Administration in this matter. To determine eligibility and get more information, please see: http://www.sba.gov/ombudsman/. The U.S. Coast Guard is providing administrative law judge services in connection with the matters set forth in this letter. Accordingly, Plexon’s answer must be filed in accordance with the instructions in § 766.5(a) of the Regulations with: 5 See 50 U.S.C. § 4819 (prescribing civil monetary penalty amount for ECRA violation); 15 C.F.R. §§ 6.3(c)(6), 6.4 (adjusting civil monetary penalty amount for inflation). Page 4 of 5 U.S. Coast Guard ALJ Docketing Center 40 S. Gay Street Baltimore, Maryland 21202-4022 In addition, a copy of Plexon’s answer must be served on BIS at the following address: Chief Counsel for Industry and Security Attention: B. Kathryn Debrason Room H-3839 14 th Street and Constitution Avenue, N.W. Washington, D.C. 20230 B. Kathryn Debrason is the attorney representing BIS in this case; any communications that Plexon may wish to have concerning this matter should occur through her. Ms. Debrason may be contacted at Kdebrason1@doc.gov or 240-805-7018. Sincerely, Steven Fisher Acting Director Office of Export Enforcement STEVEN FISHER Digitally signed by STEVEN FISHER Date: 2026.05.04 16:10:24 -04'00' Page 5 of 5 Schedule of Violations Charge No. Export Date Item Description Item Classification End User Value Per Item 1 February 10, 2022 Omniplex System & accessories 4A994.k AMMS $35,286 2 March 25, 2022 Omniplex System & accessories 4A994.k AMMS $4,167 3 May 9, 2022 Omniplex System & accessories 4A994.k AMMS $11,666 4 August 28, 2022 Omniplex System & accessories 4A994.k AMMS $6,765 5 October 5, 2022 Omniplex System & accessories 4A994.k AMMS $7,127 6 October 5, 2022 Omniplex System & accessories 4A994.k AMMS $3,563 7 August 28, 2022 Omniplex System & accessories 4A994.k AMMS $945 8 August 30, 2023 Omniplex System & accessories 4A994.k AMMS $109,202 Total Value of Shipments: $178,721
- Keywords
- Enforcement